ValproIc Acid to Potentiate Anti-EGFR Treatment Efficacy and Prevent/Revert Resistance in Colorectal Cancer

Clinical trial NCT06714357 · RECRUITING

Trial details

NCT number: NCT06714357
Sponsor: National Cancer Institute, Naples
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic

Start date: 2025-03-12
Primary completion: 2026-12-20
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.